Michelle L. Basil
General Counsel
Haemonetics Corp (HAE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $558,776 | $3,409,543 |
| 2025 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $537,870 | $2,794,443 |
| 2024 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $517,194 | $3,071,403 |
| 2023 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $498,576 | $2,990,402 |
| 2022 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $477,619 | $3,379,734 |
| 2021 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $474,204 | $2,134,912 |
| 2020 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $461,803 | $2,542,443 |
| 2019 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $440,811 | $2,148,846 |
| 2018 | Haemonetics Corp (HAE) | Executive Vice President, General Counsel | $425,818 | $2,082,208 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.